{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:28:33Z","timestamp":1777555713013,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1002\/jps.23719","type":"journal-article","created":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T17:19:13Z","timestamp":1377796753000},"page":"4072-4078","source":"Crossref","is-referenced-by-count":6,"title":["Vasomodulation Influences on the Transdermal Delivery of Ibuprofen"],"prefix":"10.1016","volume":"102","author":[{"given":"Stephen G.","family":"Carter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyula","family":"Varadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristidis","family":"Veves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim E.","family":"Riviere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.23719_bb0005","series-title":"Transdermal and topical drug delivery systems","author":"Ghosh","year":"1997"},{"key":"10.1002\/jps.23719_bb0010","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/978-3-642-00477-3_13","article-title":"Transdermal drug delivery","volume":"197","author":"Guy","year":"2010","journal-title":"Handb Exp Pharmacol"},{"issue":"2","key":"10.1002\/jps.23719_bb0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd1304","article-title":"Current status and future potential of transdermal drug delivery","volume":"3","author":"Prausnitz","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"10.1002\/jps.23719_bb0020","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nbt.1504","article-title":"Transdermal drug delivery","volume":"26","author":"Prausnitz","year":"2008","journal-title":"Nat Biotechnol"},{"issue":"2","key":"10.1002\/jps.23719_bb0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jconrel.2004.08.011","article-title":"Transdermal self-permeation enhancement of ibuprofen","volume":"100","author":"Al-Saidan","year":"2004","journal-title":"J Control Release"},{"issue":"2","key":"10.1002\/jps.23719_bb0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0378-5173(99)00340-3","article-title":"The influence of the physicochemical characteristics and pharmacokinetic properties of selected NSAID\u2019s on their transdermal absorption","volume":"193","author":"Beetge","year":"2000","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1002\/jps.23719_bb0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000069759","article-title":"Skin penetration of topical formulations of ibuprofen 5%: An in vitro comparative study","volume":"16","author":"Hadgraft","year":"2003","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"issue":"1\u20133","key":"10.1002\/jps.23719_bb0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-5173(90)90399-O","article-title":"Percutaneous absorption of ibuprofen: Vehicle effects on transport through rat skin","volume":"66","author":"Irwin","year":"1990","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1002\/jps.23719_bb0045","first-page":"559","article-title":"Comparative in vitro dermatokinetics of ibuprofen (IBP)","volume":"45","author":"Patel","year":"1990","journal-title":"Farmaco"},{"issue":"3","key":"10.1002\/jps.23719_bb0050","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2133.1993.tb11848.x","article-title":"Ibuprofen epidermal levels after topical application in vitro: Effect of formulation, application time, dose variation and occlusion","volume":"129","author":"Treffel","year":"1993","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1002\/jps.23719_bb0055","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1365-2710.2002.00439.x","article-title":"Comparative efficacy of a proprietary topical ibuprofen gel and oral ibuprofen in acute soft tissue injuries: A randomized, double-blind study","volume":"27","author":"Whitefield","year":"2002","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"10.1002\/jps.23719_bb0060","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1081\/PDT-200032991","article-title":"Two-phase melt systems of ibuprofen for enhanced membrane permeation","volume":"9","author":"Kang","year":"2004","journal-title":"Pharm Dev Technol"},{"issue":"1\u20133","key":"10.1002\/jps.23719_bb0065","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0168-3659(97)00153-3","article-title":"Transdermal delivery from eutectic systems: Enhanced permeation of a model drug, ibuprofen","volume":"50","author":"Stott","year":"1998","journal-title":"J Control Release"},{"issue":"11","key":"10.1002\/jps.23719_bb0070","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1002\/jps.23270","article-title":"Interindividual variation in transdermal and oral drug deliveries","volume":"101","author":"Levin","year":"2012","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1002\/jps.23719_bb0075","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000086666","article-title":"Liposomes and niosomes as topical drug delivery systems","volume":"18","author":"Choi","year":"2005","journal-title":"Skin Pharmacol Physiol"},{"issue":"9","key":"10.1002\/jps.23719_bb0080","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00403-011-1166-4","article-title":"Liposomal systems as drug delivery vehicles for dermal and transdermal applications","volume":"303","author":"Pierre MB, Dos Santos Miranda Costa I","year":"2011","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"10.1002\/jps.23719_bb0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0939-6411(01)00166-7","article-title":"Passive skin penetration enhancement and its quantification in vitro","volume":"52","author":"Moser","year":"2001","journal-title":"Eur J Pharm Biopharm"},{"issue":"6","key":"10.1002\/jps.23719_bb0090","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000107575","article-title":"Percutaneous penetration enhancers: An overview","volume":"20","author":"Thong","year":"2007","journal-title":"Skin Pharmacol Physiol"},{"issue":"7","key":"10.1002\/jps.23719_bb0095","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jps.2600800702","article-title":"Effects of vasoactive drugs on transdermal lidocaine iontophoresis","volume":"80","author":"Riviere","year":"1991","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1002\/jps.23719_bb0100","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1023\/A:1018985323001","article-title":"Determination of lidocaine concentrations in skin after transdermal iontophoresis: Effects of vasoactive drugs","volume":"9","author":"Riviere","year":"1992","journal-title":"Pharm Res"},{"issue":"6","key":"10.1002\/jps.23719_bb0105","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/jps.2600830605","article-title":"Effects of vasoconstriction on dermal pharmacokinetics and local tissue distribution of compounds","volume":"83","author":"Singh","year":"1994","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1002\/jps.23719_bb0110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.yrtph.2004.10.001","article-title":"Dermal absorption of 2,4-D: A review of species differences","volume":"41","author":"Ross","year":"2005","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1002\/jps.23719_bb0115","first-page":"H1613","article-title":"Permissive role for nitric oxide in active thermoregulatory vasodilation in rabbit ear","volume":"269","author":"Farrell","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1002\/jps.23719_bb0120","first-page":"H1355","article-title":"A role for nitric oxide in active thermoregulatory vasodilation","volume":"264","author":"Taylor","year":"1993","journal-title":"Am J Physiol"},{"issue":"1\u20132","key":"10.1002\/jps.23719_bb0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0378-5173(95)04412-4","article-title":"Formulation development of a transdermal drug delivery system for amlodipine","volume":"133","author":"McDaid","year":"1996","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1002\/jps.23719_bb0130","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/lsm.20590","article-title":"Laser treatments on skin enhancing and controlling transdermal delivery of 5-fluorouracil","volume":"40","author":"G\u00f3mez","year":"2008","journal-title":"Lasers Surg Med"},{"issue":"10","key":"10.1002\/jps.23719_bb0135","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/jps.20152","article-title":"Effect of chemical enhancers and iontophoresis on thiocolchicoside permeation across rabbit and human skin in vitro","volume":"93","author":"Artusi","year":"2004","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1002\/jps.23719_bb0140","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.colsurfb.2010.03.055","article-title":"Effect of formulations variables on the in vitro percutaneous permeation of Sodium Diclofenac from new vesicular systems obtained from Pluronic triblock copolymers","volume":"79","author":"Tavano","year":"2010","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"2","key":"10.1002\/jps.23719_bb0145","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/0378-4347(94)00018-2","article-title":"Highperformance liquid chromatographic assay for ibuprofen in whole blood using solid-phase extraction","volume":"654","author":"Sochor","year":"1994","journal-title":"J Chromatogr B Biomed Appl"},{"issue":"3","key":"10.1002\/jps.23719_bb0150","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2337\/diabetes.47.3.457","article-title":"Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration","volume":"47","author":"Veves","year":"1998","journal-title":"Diabetes"},{"issue":"8","key":"10.1002\/jps.23719_bb0155","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.2337\/diacare.21.8.1339","article-title":"Differences in foot and forearm skin microcirculation in diabetic patients with and without neuropathy","volume":"21","author":"Arora","year":"1998","journal-title":"Diabetes Care"},{"issue":"3\u20134","key":"10.1002\/jps.23719_bb0160","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/(SICI)1098-2299(199903\/04)46:3\/4<309::AID-DDR17>3.0.CO;2-H","article-title":"Targeting local tissues by transdermal application: Understanding drug physicochemical properties that best exploit protein binding and blood flow effects","volume":"46","author":"Cross","year":"1999","journal-title":"Drug Dev Res"},{"issue":"6","key":"10.1002\/jps.23719_bb0165","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/jps.2600810628","article-title":"Pharmacokinetic implications of changing blood flow in skin","volume":"81","author":"Riviere","year":"1992","journal-title":"J Pharm Sci"},{"issue":"11","key":"10.1002\/jps.23719_bb0170","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/jps.2600821103","article-title":"Model describing transdermal ion-tophoretic delivery of lidocaine incorporating consideration of cutaneous microvascular state","volume":"82","author":"Williams","year":"1993","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1002\/jps.23719_bb0175","first-page":"470","article-title":"Histamine 2 receptor-mediated immunomodulation in the mouse. I. Immunomodulation by the H2 agonist tolazoline","volume":"35","author":"Van Dijk","year":"1979","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"10.1002\/jps.23719_bb0180","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/sj.bjp.0701296","article-title":"Characterization of alpha 2-adrenoceptors mediating contraction of dog saphenous vein: Identity with the human alpha 2A subtype","volume":"121","author":"MacLennan","year":"1997","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1002\/jps.23719_bb0185","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0304-4165(84)90257-5","article-title":"Assessment of selective inhibition of rat cerebral cortical calcium-independent and calcium-dependent phosphodiesterases in crude extracts using deoxycyclic AMP and potassium ions","volume":"797","author":"Davis","year":"1984","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1002\/jps.23719_bb0190","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1476-5381.1984.tb10125.x","article-title":"Lack of a causal relationship between the vasodilator effect of papaverine and cyclic AMP production in the dog basilar artery","volume":"83","author":"Fujioka","year":"1984","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1002\/jps.23719_bb0195","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1476-5381.1994.tb14763.x","article-title":"Relationship between cytosolic calcium concentration and force in the papaverineinduced relaxation of medial strips of pig coronary artery","volume":"111","author":"Aoki","year":"1994","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1002\/jps.23719_bb0200","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1056-8727(02)00256-8","article-title":"Topical methyl nicotinate-induced skin vasodilation in diabetic neuropathy","volume":"17","author":"Caselli","year":"2003","journal-title":"J Diabetes Complications"},{"issue":"3","key":"10.1002\/jps.23719_bb0205","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/A:1018834021066","article-title":"Self promotion of deep tissue penetration and distribution of methylsalicylate after topical application","volume":"16","author":"Cross","year":"1999","journal-title":"Pharm Res"},{"issue":"12","key":"10.1002\/jps.23719_bb0210","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/jps.2600831208","article-title":"Pharmacologic modulation of the cutaneous vasculature in the isolated perfused porcine skin flap","volume":"83","author":"Rogers","year":"1994","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1002\/jps.23719_bb0215","doi-asserted-by":"crossref","first-page":"014025","DOI":"10.1117\/1.2166370","article-title":"Comparison of blood flow to the cutaneous temperature and redness after topical application of benzyl nicotinate","volume":"11","author":"Jacobi","year":"2006","journal-title":"J Biomed Opt"},{"issue":"6","key":"10.1002\/jps.23719_bb0220","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/1523-1747.ep12535042","article-title":"Noninvasive assessment of local nicotinate pharmacodynamics by photoplethysmography","volume":"80","author":"Tur","year":"1983","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1002\/jps.23719_bb0225","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1152\/japplphysiol.01167.2000","article-title":"Vascular and neural mechanisms of ACh-mediated vasodilation in the forearm cutaneous microcirculation","volume":"92","author":"Berghoff","year":"2002","journal-title":"J Appl Physiol"},{"issue":"8","key":"10.1002\/jps.23719_bb0230","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/hh2001.098351","article-title":"Prostaglandin H synthase and vascular function","volume":"89","author":"Davidge","year":"2001","journal-title":"Circ Res"},{"issue":"3","key":"10.1002\/jps.23719_bb0235","first-page":"1398","article-title":"Down-regulation of nitric oxide production by ibuprofen in human volunteers","volume":"289","author":"Vandivier","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1002\/jps.23719_bb0240","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/01.RES.86.6.663","article-title":"Biphasic actions of prostaglandin E(2) on the renal afferent arteriole: Role of EP(3) and EP(4) receptors","volume":"86","author":"Tang","year":"2000","journal-title":"Circ Res"},{"issue":"3","key":"10.1002\/jps.23719_bb0245","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2230.1990.tb02071.x","article-title":"Objective assessment of topical corticosteroids and non-steroidal antiinflammatory drugs in methyl-nicotinate-induced skin inflammation","volume":"15","author":"Duteil","year":"1990","journal-title":"Clin Exp Dermatol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915308364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915308364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T12:34:05Z","timestamp":1563798845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915308364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0022354915308364"],"URL":"https:\/\/doi.org\/10.1002\/jps.23719","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}